Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results

Axcella to Report Second Quarter 2020 Financial Results and Hold Conference Call on August 5, 2020

Axcella Announces Patent Issuances Covering AXA1665

Axcella to Present at Goldman Sachs 41st Annual Global Healthcare Conference

Axcella Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option

Axcella Announces Pricing of Public Offering of Common Stock

Axcella Reports First Quarter Financial Results and Provides Business Update

Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD

Axcella to Report Top-Line Data from AXA1125-003 in Adult Subjects with NAFLD on May 6, 2020

Axcella to Hold Virtual-Only 2020 Annual Meeting of Stockholders